Clinical trial
Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And…
NCT00394030 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00394030 |
|---|---|
| Title | Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers |
| Official title | An Open-Label, Randomized, Multi-Site Study to Assess the Pharmacokinetics of Single Subcutaneous Injections of 16mg and 64mg of GSK716155 Administered at Three Different Injection Sites in Adult Male and Female Subjects With Type 2 Diabetes and of Single Subcutaneous Injections of 16mg and 64mg of… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | GSK716155 subcutaneous injections |
| Enrollment | 63 |
| Start date | Oct 16, 2006 |
| Primary completion | Mar 20, 2007 |
| Completion | Mar 20, 2007 |
| First posted | Oct 31, 2006 |
| Last update posted | Sep 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: